This research was conducted to assess whether a methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism resulted in hyperhomocysteinemia as a potential genetic risk factor for CAD. The gene discussed is MTHFR; the disease is hyperhomocysteinemia.